Online Cognitive Control Training for Remitted Depressed Patients

November 8, 2022 updated by: University Ghent
This study evaluates the effectiveness of an internet-delivered cognitive control training as a preventive intervention for remitted depressed patients. Half of the participants will receive a cognitive control training, while the other half will receive a low cognitive load training that acts as an active control condition.

Study Overview

Detailed Description

Prospective studies have linked impaired cognitive control to increased cognitive vulnerability for future depression. Importantly, experimental studies indicate that cognitive control training can be used to reduce rumination and depressive symptomatology in MDD (major depressive disorder) and RMD (remitted depressed) samples. Provided that remitted depressed patients form a high-risk group for developing future depressive episodes, the current study will explore whether an internet-delivered cognitive control training can be used to reduce vulnerability for future depression in remitted depressed patients.

A computer training, consisting of 10 sessions of 15 minutes each, will be administered to participants, which are remitted depressed patients. This training can either be a cognitive control training, using an adaptive paced auditory serial addition task, or an active control training, with a low cognitive load task.

Dependent variables will be assessed pre- and post-training, as well as 3 and 6 months after the training, and consist of depressive symptomatology, related variables and cognitive control measures.

Study Type

Interventional

Enrollment (Actual)

68

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Oost-Vlaanderen
      • Gent, Oost-Vlaanderen, Belgium, 9000
        • Ghent University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • History of ≥ 1 depressive episodes (major or bipolar)
  • Currently in stable full or partial remission (≥ 3 months)

Exclusion Criteria:

  • Major depressive disorder (current or less than 3 months in remission)
  • Bipolar disorder (current or less than 3 months in remission)
  • Psychotic disorder (current and/or previous)
  • Neurological impairments (current and/or previous)
  • Excessive substance abuse (current and/or previous)
  • No ongoing psychotherapeutic treatment (maintenance treatment is allowed, but with a frequency of less than once every three weeks)
  • Use of antidepressant medication is allowed if kept at a constant level

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Cognitive Control Training
A cognitive control training, consisting of 10 sessions of 15 minutes each, will be administered. The task in this training is an adaptive paced auditory serial addition task, where participants need to click on the sum of the last two heard digits.
10 sessions of an adaptive paced auditory serial addition task, each lasting 15 minutes, over the course of two weeks.
Active Comparator: Active Control Training
An active control training, consisting of 10 sessions of 15 minutes each, will be administered. The task in this training is an adaptive low load cognitive task, where participants need to click on the last heard digit.
10 sessions of an low cognitive load task, each lasting 15 minutes, over the course of two weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in depressive symptomatology
Time Frame: Assessed at pre-training assessment and at 6 months follow-up
Measured by the Beck Depression Inventory - II (BDI-II)
Assessed at pre-training assessment and at 6 months follow-up
Change in depressive symptomatology
Time Frame: Assessed at pre-training assessment, at post-training assessment (within 1 week of completing the training), at 3 months follow-up and at 6 months follow-up
Measured by the Depression Anxiety Stress Scales (DASS)
Assessed at pre-training assessment, at post-training assessment (within 1 week of completing the training), at 3 months follow-up and at 6 months follow-up
Change in depressive rumination (brooding)
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Measured by the Ruminative Response Scale (RRS), especially the brooding subscale
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in cognitive emotion regulation strategies
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Measured by the Cognitive Emotion Regulation Questionnaire (CERQ)
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Change in quality of life
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Measured by the Quality of Life in Depression Scale (QLDS)
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Remission from depression
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Measured by the Remission of Depression Questionnaire (RDQ)
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Resilience
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Measured by the Connor-Davidson Resilience Scale (CD-RISC)
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
User engagement
Time Frame: Assessed at post-training assessment (within 1 week of completing the training) and at 3 months follow-up
Measured by the User Engagement Scale (UES)
Assessed at post-training assessment (within 1 week of completing the training) and at 3 months follow-up
Threatening experiences
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Measured by the List of Threatening Experiences (LTE)
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Effortful control
Time Frame: Assessed at pre-training assessment and at 6 months follow-up
Measured by the subscale Effortful Control (EC) from the Adult Temperament Questionnaire (ATQ)
Assessed at pre-training assessment and at 6 months follow-up
Credibility and Expectancy
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Measured by the Credibility/Expectancy Questionnaire
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Behavioral measure for cognitive control
Time Frame: Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up
Measured by the non-adaptive Paced Auditory Serial Addition Task (PASAT)
Assessed at pre- and post-training assessment (within 1 week of completing the training) and at 3 and 6 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ernst HW Koster, PhD, University Ghent

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2017

Primary Completion (Actual)

March 13, 2019

Study Completion (Actual)

March 13, 2019

Study Registration Dates

First Submitted

August 18, 2017

First Submitted That Met QC Criteria

September 8, 2017

First Posted (Actual)

September 12, 2017

Study Record Updates

Last Update Posted (Actual)

November 9, 2022

Last Update Submitted That Met QC Criteria

November 8, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • B/14730/RMD

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Major Depression in Remission

Clinical Trials on Cognitive control training

Subscribe